Cargando…

In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models

OBJECTIVE: We examined whether it is cost-effective to measure free thyroxine (FT4) in addition to thyrotropin (thyroid-stimulating hormone (TSH)) on all requests for thyroid function tests from primary care on adult patients. BACKGROUND: Hypopituitarism occurs in about 4 people per 100 000 per year...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shine, Brian, James, Tim, Adler, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677967/ https://www.ncbi.nlm.nih.gov/pubmed/31362968 http://dx.doi.org/10.1136/bmjopen-2019-029369

Ejemplares similares

Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models
por: Moriarty, Frank, et al.
Publicado: (2019)

The Impact of Seasonal Changes on Thyroxine and Thyroid-Stimulating Hormone in Newborns
por: McMahon, Rebecca, et al.
Publicado: (2021)

Dose Adjustments of Hydrocortisone and L-thyroxine in Hypopituitarism Associated with Cholestasis
por: Higuchi, Asako, et al.
Publicado: (2006)

Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
por: Mistry, Hema, et al.
Publicado: (2012)

Evaluation of Thyroid‐Stimulating Hormone, Total Thyroxine, and Free Thyroxine Concentrations in Hyperthyroid Cats Receiving Methimazole Treatment
por: Aldridge, C., et al.
Publicado: (2015)

Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model
por: Neyt, Mattias, et al.
Publicado: (2011)

Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study
por: Han, Mingyang, et al.
Publicado: (2022)

Cost effectiveness of screening for intracranial aneurysms among patients with bicuspid aortic valve: a Markov modelling study
por: Chen, Jigang, et al.
Publicado: (2021)

Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model
por: Sun, Chengyao, et al.
Publicado: (2021)

Circulating Thyroxine, Thyroid-Stimulating Hormone, and Hypothyroid Status and the Risk of Prostate Cancer
por: Mondul, Alison M., et al.
Publicado: (2012)

Thyroid-Stimulating Hormone and Free Thyroxine Alterations in Subjects with Occupational Hearing Loss
por: Ranjbar, Nastaran, et al.
Publicado: (2021)

Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status
por: Van Uytfanghe, Katleen, et al.
Publicado: (2023)

Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis
por: Huang, Xiaoting, et al.
Publicado: (2020)

Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer
por: Aguiar, Pedro Nazareth, et al.
Publicado: (2019)

Thyroxine and Thyroid-Stimulating Hormone in Own Mother’s Milk, Donor Milk, and Infant Formula
por: Vass, Réka A., et al.
Publicado: (2022)

Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model
por: Dainelli, Livia, et al.
Publicado: (2017)

Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits – a Markov model-based simulation study
por: Nguyen, Dieu, et al.
Publicado: (2023)

Evaluation of assays for thyroxine, triodotyronine and thyroid-stimulating hormone on the ARIA II automated radioimmunoassay instrument
por: Duffy, M. J., et al.
Publicado: (1983)

Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model
por: Delgleize, Emmanuelle, et al.
Publicado: (2016)

Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results
por: Zhou, Qin, et al.
Publicado: (2021)

Cost-utility analysis of transcranial direct current stimulation (tDCS) in non-treatment-resistant depression: the DISCO randomised controlled study protocol
por: Sauvaget, Anne, et al.
Publicado: (2020)

Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)
por: Panca, Monica, et al.
Publicado: (2018)

Risk factors for low plasma thyroxine and high plasma thyroid-stimulating hormone concentrations in dogs with non-thyroidal diseases
por: NISHII, Naohito, et al.
Publicado: (2019)

Metastatic Follicular Thyroid Carcinoma as a Cause of Low Serum Thyroxine with a Normal Thyroid Stimulating Hormone Level
por: Loh, Leh Teng, et al.
Publicado: (2017)

Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in Thailand
por: Dilokthornsakul, P, et al.
Publicado: (2016)

Telerehabilitation after total knee replacement in Italy: cost-effectiveness and cost-utility analysis of a mixed telerehabilitation-standard rehabilitation programme compared with usual care
por: Fusco, Francesco, et al.
Publicado: (2016)

Is multimodal occupational therapy in addition to usual care cost-effective in people with thumb carpometacarpal osteoarthritis? A cost-utility analysis of a randomised controlled trial
por: Tveter, Anne Therese, et al.
Publicado: (2023)

Study of thyroid hormones free triiodothyronine (FT3), free thyroxine (FT4) and thyroid stimulating hormone (TSH) in subjects with dental fluorosis
por: Hosur, Mahadevi B., et al.
Publicado: (2012)

The Effects of Simvastatin on the Serum Concentrations of Thyroid Stimulating Hormone and Free Thyroxine in Hypothyroid Patients Treated with Levothyroxine
por: Abbasinazari, Mohammad, et al.
Publicado: (2011)

Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure
por: Anastasiou, Olympia, et al.
Publicado: (2015)

A genome-wide association study of thyroid stimulating hormone and free thyroxine in Danish children and adolescents
por: Nielsen, Tenna Ruest Haarmark, et al.
Publicado: (2017)

Follow-up of infants with congenital hypothyroidism and low total thyroxine/thyroid stimulating hormone on newborn screen
por: McCormick, Quinn, et al.
Publicado: (2019)

Neratinib plus capecitabine versus lapatinib plus capecitabine as the third-line therapy for HER2-positive metastatic breast cancer in China: a cost-effectiveness analysis
por: Wu, Yue, et al.
Publicado: (2022)

Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA
por: Zeng, Xiaohui, et al.
Publicado: (2019)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada
por: Wong, William W L, et al.
Publicado: (2023)

A systematic review of the cost and cost-effectiveness of electronic discharge communications
por: Sevick, Laura K, et al.
Publicado: (2017)

Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study
por: Schofield, D., et al.
Publicado: (2020)

How well does the capillary thyroid-stimulating hormone test for newborn thyroid screening predict the venous free thyroxine level?
por: Pokrovska, Tzveta, et al.
Publicado: (2016)

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
por: Restelli, Umberto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m2tv4jrk4p8vo0rsbihd4lmjjc